Marc Lütgehetmann

16.5k citations

221 papers · 5.8k indexed · h-index 40

Impact in

Hepatology top 0.2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology

Papers in

Hepatology 88
- Hepatitis C virus research 58
- Hepatitis Viruses Studies and Epidemiology 37
Infectious Diseases 91
- SARS-CoV-2 and COVID-19 Research 48
- COVID-19 Clinical Research Studies 30
- SARS-CoV-2 detection and testing 24
- Viral gastroenteritis research and epidemiology 20

Co-authors: Maura Dandri Tassilo Volz Ansgar W. Lohse Lena Allweiss Joerg Petersen Martin Aepfelbacher Stephan Urban Julian Schulze zur Wiesch
Journals: Journal of Hepatology (27 papers)Journal of Clinical Virology (9 papers)Scientific Reports (8 papers)Journal of Clinical Microbiology (7 papers)Hepatology (7 papers)
Partner nations: Germany United States France

In The Last Decade

Marc Lütgehetmann

209 papers receiving 5.7k citations

Peers

Countries citing papers authored by Marc Lütgehetmann

Since Specialization

Citations

This map shows the geographic impact of Marc Lütgehetmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lütgehetmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lütgehetmann more than expected).

Fields of papers citing papers by Marc Lütgehetmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Lütgehetmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lütgehetmann. The network helps show where Marc Lütgehetmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Lütgehetmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Lütgehetmann Line = papers co-authored together Marc Lütgehetmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prospective evaluation of real-world performance and clinical impact of the Biofire FilmArray joint infection panel Microbiology Spectrum ·Benjamin Berinson, Konstantin Tanida, Laura Spenke, Lukas Krivec, Johannes Keller, Tim Rolvien, Martin Christner, Marc Lütgehetmann, Martin Aepfelbacher, Till Orla Klatte, Holger Rohde	2025	1
2	Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies Journal of Hepatology ·Lena Allweiss, Annika Volmari, Vithika Suri, Jeffrey J. Wallin, John F. Flaherty, Dmitry Manuilov, Bryan Downie, Marc Lütgehetmann, Jan‐Hendrik Bockmann, Stephan Urban, Heiner Wedemeyer, Maura Dandri	2024	18
3	A unified framework for diagnostic test development and evaluation during outbreaks of emerging infections SHILAP Revista de lepidopterología ·Madhav Chaturvedi, Denise Köster, Patrick M. Bossuyt, Oke Gerke, Annette Jurke, Mirjam Kretzschmar, Marc Lütgehetmann, Rafael Mikolajczyk, Johannes B. Reitsma, Nicole Schneiderhan‐Marra, Uwe Siebert, Carina Stekly, Christoph Ehret, Nicole Rübsamen, André Karch, Antonia Zapf	2024	0
4	High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study United European Gastroenterology Journal ·P. von der Schulenburg, A. Herting, Aenne Harberts, Marc Lütgehetmann, Jacqueline Jahnke-Triankowski, Sven Pischke, Felix Piecha, Andreas Drolz, Vincent Jörg, Peter Hübener, Malte H. Wehmeyer, Marylyn M. Addo, Lutz Fischer, Ansgar W. Lohse, Julian Schulze zur Wiesch, Martina Sterneck	2024	1
5	Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure Gut ·Lena Allweiss, Barbara Testoni, Yu Mei, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Lütgehetmann, Haitao Guo, Stephan Urban, Simon P. Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri	2023	43
6	High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022 Infection ·Marlene Ettemeyer, M. E. Florey, Konstantin Tanida, Johannes Jochum, Ulf Schulze‐Sturm, Marc Lütgehetmann, Michael Baehr, Marylyn M. Addo, Stefan Schmiedel, Holger Rohde, Till Koch	2023	1
7	Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2 Frontiers in Immunology ·Luís Fonseca Brito, Silvia Tödter, Julian Kottlau, Kathrin Cermann, Anthea Spier, Elina Petersen, Ines Schäfer, Raphael Twerenbold, Martin Aepfelbacher, Marc Lütgehetmann, Felix R. Stahl	2023	2
8	Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment JHEP Reports ·Katja Giersch, Paulina Perez-Gonzalez, Lennart Hendricks, Nora Goldmann, Jonathan Kolbe, Lennart Hermanussen, Jan-Hendrick Bockmann, Tassilo Volz, Annika Volmari, Lena Allweiss, Joerg Petersen, Dieter Glebe, Marc Lütgehetmann, Maura Dandri	2023	6
9	Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave Viruses ·A. Herting, Jacqueline Jahnke-Triankowski, Aenne Harberts, Golda Schaub, Marc Lütgehetmann, Darius F. Ruether, Lutz Fischer, Marylyn M. Addo, Ansgar W. Lohse, Julian Schulze zur Wiesch, Martina Sterneck	2023	7
10	SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease United European Gastroenterology Journal ·Paul Duengelhoef, Johannes Hartl, Darius F. Rüther, Silja Steinmann, Thomas Theo Brehm, Jan Philipp Weltzsch, Fabian Glaser, Golda Schaub, Martina Sterneck, Marcial Sebode, Christina Weiler‐Normann, Marylyn M. Addo, Marc Lütgehetmann, Friedrich Haag, Christoph Schramm, Julian Schulze zur Wiesch, Ansgar W. Lohse	2022	23
11	High‐resolution analysis of individual spike peptide‐specific CD4⁺ T‐cell responses in vaccine recipients and COVID‐19 patients Clinical & Translational Immunology ·Hendrik Karsten, Leon Cords, Tim Westphal, Maximilian Knapp, Thomas Theo Brehm, Lennart Hermanussen, Till F. Omansen, Stefan Schmiedel, Robin Woost, Vanessa Ditt, Sven Peine, Marc Lütgehetmann, Samuel Huber, Christin Ackermann, Melanie Wittner, Marylyn M. Addo, Alessandro Sette, John Sidney, Julian Schulze zur Wiesch	2022	8
12	Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study Microbiology Spectrum ·Marcel S. Woo, Thomas Theo Brehm, Marlene Fischer, Andreas Heyer, Dominic Wichmann, Sabine Jordan, Dominik Nörz, Marc Lütgehetmann, Marylyn M. Addo, Ansgar W. Lohse, Stefan Schmiedel, Stefan Kluge, Julian Schulze zur Wiesch	2022	4
13	Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform Journal of Medical Microbiology ·Dominik Nörz, Armin Hoffmann, Martin Aepfelbacher, Susanne Pfefferle, Marc Lütgehetmann	2021	26
14	Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo Gut ·Lena Allweiss, Katja Giersch, Andrea Pirosu, Tassilo Volz, Robert Muench, Rudolf K. Beran, Stephan Urban, Hassan Javanbakht, Simon P. Fletcher, Marc Lütgehetmann, Maura Dandri	2021	60
15	Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment Cancers ·Susanne Ghandili, Martin Schönlein, Marc Lütgehetmann, Julian Schulze zur Wiesch, Heiko Becher, Carsten Bokemeyer, Marianne Sinn, Katja Weisel, Lisa Leypoldt	2021	24
16	Fatal COVID-19 in a Child with Persistence of SARS-CoV-2 Despite Extensive Multidisciplinary Treatment: A Case Report Children ·Sofia Apostolidou, Theresa Harbauer, Peter Lasch, Daniel Biermann, Maja Hempel, Marc Lütgehetmann, Susanne Pfefferle, Jochen Herrmann, André Rüffer, Konrad Reinshagen, Rainer Kozlik‐Feldmann, Anna Gieras, Inga Kniep, Jun Oh, Dominique Singer, Chinedu Ulrich Ebenebe, Robin Kobbe	2021	5
17	Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19 PLoS Pathogens ·Janna Heide, Sophia Schulte, Matin Kohsar, Thomas Theo Brehm, Marissa Herrmann, Hendrik Karsten, Matthias Marget, Sven Peine, Alexandra M. Johansson, Alessandro Sette, Marc Lütgehetmann, William W. Kwok, John Sidney, Julian Schulze zur Wiesch	2021	36
18	Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic International Journal of Hygiene and Environmental Health ·Thomas Theo Brehm, M.C. Thompson, Felix Ullrich, Dorothee Schwinge, Marylyn M. Addo, Anthea Spier, Johannes K.‐M. Knobloch, Martin Aepfelbacher, Ansgar W. Lohse, Marc Lütgehetmann, Julian Schulze zur Wiesch	2021	11
19	Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study International Journal of Hygiene and Environmental Health ·Thomas Theo Brehm, Dorothee Schwinge, Sibylle Lampalzer, Veronika Schlicker, Julia Küchen, M.C. Thompson, Felix Ullrich, Samuel Huber, Stefan Schmiedel, Marylyn M. Addo, Marc Lütgehetmann, Johannes K.‐M. Knobloch, Julian Schulze zur Wiesch, Ansgar W. Lohse	2020	28
20	Forced Activation of β-Catenin Signaling Supports the Transformation of hTERT -Immortalized Human Fetal Hepatocytes Molecular Cancer Research ·Henning Wege, Denise Heim, Marc Lütgehetmann, Judith Dierlamm, Ansgar W. Lohse, Tim H. Brümmendorf	2011	13

About Marc Lütgehetmann

Marc Lütgehetmann is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Modeling and Simulation, having authored 221 papers that have together received 5.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (71 papers), Hepatitis C virus research (58 papers), SARS-CoV-2 and COVID-19 Research (48 papers), Hepatitis Viruses Studies and Epidemiology (37 papers), Liver Disease Diagnosis and Treatment (34 papers), COVID-19 Clinical Research Studies (30 papers), SARS-CoV-2 detection and testing (24 papers) and Viral gastroenteritis research and epidemiology (20 papers). The work is most often cited by research in Hepatology (2.7k citations), Infectious Diseases (1.9k citations), Epidemiology (3.1k citations), Virology (255 citations) and Neurology (419 citations). Marc Lütgehetmann has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Maura Dandri, Tassilo Volz, Ansgar W. Lohse, Lena Allweiss, Joerg Petersen, Martin Aepfelbacher, Stephan Urban, Julian Schulze zur Wiesch, Katja Giersch and Susanne Pfefferle. Their work appears in journals such as Journal of Hepatology, Journal of Clinical Virology, Scientific Reports, Journal of Clinical Microbiology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact